Stoke Therapeutics Inc (NASDAQ:STOK)
| 7.86 Delayed Data As of 3:59pm ET |  -0.13 / -1.63%Today’s Change | 6.88 Today|||52-Week Range 24.97 | -14.84% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2017 | 2018 | -- | -- | |||
| Operating Activities | Net Income / Starting Line | -5.6M | -12.5M | -- | -- | |
| Depreciation | 113.0K | 214.0K | -- | -- | ||
| Total Other Cash Flow | 30.0K | 250.0K | -- | -- | ||
| Funds From Operations | -5.4M | -12.1M | -- | -- | ||
| Funds From/For Other Operating Expenses | -31.0K | -1.1M | -- | -- | ||
| Net Cash Flow - Operating Activities | -5.4M | -11.0M | -- | -- | ||
| Investing | Capital Expenditures | -113.0K | -935.0K | -- | -- | |
| Fixed Asset Disposal | 0.00 | 10.0K | -- | -- | ||
| Net Cash Flow Investing | -113.0K | -925.0K | -- | -- | ||
| Financing | Short Term Borrowings | 3.0M | 0.00 | -- | -- | |
| Long Term Borrowings | 0.00 | 0.00 | -- | -- | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | -- | -- | -- | |
| Net Proceeds Stock Sale | 3.0M | 115.6M | -- | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | -- | -- | -- | |
| Common Dividends | 0.00 | 0.00 | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | -- | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | -- | -- | -- | |
| Other Uses - Financing | 1.0K | 2.0K | -- | -- | ||
| Net Cash Flow - Financing | 6.0M | 115.6M | -- | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 477.0K | 103.8M | -- | -- | ||
